Mineralys Therapeutics, Inc. (MLYS) Operating cash flow 2022–2025
Mineralys Therapeutics, Inc. (MLYS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$142.4MFY2025 · since FY2022: -$29.2M → -$142.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$142.4M | +14.4% |
| FY2024 | -$166.3M | -104.9% |
| FY2023 | -$81.2M | -177.8% |
| FY2022 | -$29.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice